5820 related articles for article (PubMed ID: 2979857)
1. Bone marrow and peripheral blood modifications in C57BL mice administered with cyclophosphamide and levan.
Siegal A; Kopel S; Bar-Sela S; Davidai G; Yavetz H; Leibovici J
In Vivo; 1988; 2(5):349-59. PubMed ID: 2979857
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclophosphamide and levan treatment on bone marrow and peripheral blood cells in B16-F10 melanoma-bearing mice.
Leibovici J; Siegal A; Kopel S; Davidai G; Yavetz H
Int J Immunopharmacol; 1989; 11(2):133-47. PubMed ID: 2703278
[TBL] [Abstract][Full Text] [Related]
3. Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels.
Evans R
Am J Pathol; 1980 Jun; 99(3):667-84. PubMed ID: 7386598
[TBL] [Abstract][Full Text] [Related]
4. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
[TBL] [Abstract][Full Text] [Related]
5. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
[TBL] [Abstract][Full Text] [Related]
6. Opposite effects on tumor growth depending on dose of an immunomodulatory polysaccharide with or without cyclophosphamide.
Leibovici J; Kopel S; Wolman M
Anticancer Res; 1985; 5(5):553-8. PubMed ID: 4062258
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic examination of bone marrow cells and peripheral lymphocytes in rats exposed to cyclophosphamide.
Topinková E; Srám RJ
Folia Biol (Praha); 1982; 28(5):302-10. PubMed ID: 7173448
[TBL] [Abstract][Full Text] [Related]
8. Effect of tumor inhibitory and stimulatory doses of levan, alone and in combination with cyclophosphamide, on spleen and lymph nodes.
Leibovici J; Kopel S; Siegal A; Gal-Mor O
Int J Immunopharmacol; 1986; 8(4):391-403. PubMed ID: 3744640
[TBL] [Abstract][Full Text] [Related]
9. Direct antitumor effect of the polysaccharide levan in mice: effects of drug concentration and time and temperature of incubation.
Leibovici J; Stark Y
J Natl Cancer Inst; 1984 Jun; 72(6):1417-20. PubMed ID: 6587158
[TBL] [Abstract][Full Text] [Related]
10. Effects of cyclophosphamide on murine bone marrow and splenic megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
Yeager AM; Levin FC; Levin J
J Cell Physiol; 1982 Aug; 112(2):222-8. PubMed ID: 7119022
[TBL] [Abstract][Full Text] [Related]
11. The influence of 2-chlorodeoxyadenosine alone and in combination with cyclophosphamide or methotrexate on normal hematopoiesis in mice.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(3):281-7. PubMed ID: 7902635
[TBL] [Abstract][Full Text] [Related]
12. The influence of cyclophosphamide on lymph node and peripheral blood lymphocytes in mice.
Mackiewicz U; Brelińska-Peczalska R; Konys J
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):375-80. PubMed ID: 749786
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide-induced changes in the cellular composition of a methylcholanthrene-induced tumor and their relation to bone marrow and blood leukocyte levels.
Evans R; Madison LD; Eidlen DM
Cancer Res; 1980 Feb; 40(2):395-402. PubMed ID: 7356522
[No Abstract] [Full Text] [Related]
14. Accumulation and persistence of cyclophosphamide-induced sister chromatid exchange in murine peripheral blood lymphocytes.
Takeshita T; Conner MK
Cancer Res; 1984 Sep; 44(9):3820-4. PubMed ID: 6744298
[TBL] [Abstract][Full Text] [Related]
15. A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.
Kiss J; Kunstár A; Fajka-Boja R; Dudics V; Tóvári J; Légrádi A; Monostori E; Uher F
Exp Hematol; 2007 Feb; 35(2):305-13. PubMed ID: 17258079
[TBL] [Abstract][Full Text] [Related]
16. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
Zhu XL; Chen AF; Lin ZB
J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
[TBL] [Abstract][Full Text] [Related]
17. Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioning.
Prigozhina TB; Elkin G; Khitrin S; Slavin S
Exp Hematol; 2004 Nov; 32(11):1110-7. PubMed ID: 15539090
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of total saponins from stem and leaf of Panax ginseng against cyclophosphamide-induced genotoxicity and apoptosis in mouse bone marrow cells and peripheral lymphocyte cells.
Zhang QH; Wu CF; Duan L; Yang JY
Food Chem Toxicol; 2008 Jan; 46(1):293-302. PubMed ID: 17904265
[TBL] [Abstract][Full Text] [Related]
19. Effect of H2 antagonists cimetidine and famotidine on the hemotoxicity of cyclophosphamide.
Lerza RA; Bogliolo GV; Mencoboni MP; Saviane AG; Pannacciulli IM
Anticancer Res; 1988; 8(6):1241-5. PubMed ID: 2905881
[TBL] [Abstract][Full Text] [Related]
20. Altered mouse bone marrow glutathione and glutathione transferase levels in response to cytotoxins.
Adams KJ; Carmichael J; Wolf CR
Cancer Res; 1985 Apr; 45(4):1669-73. PubMed ID: 3978635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
